Correct. I don't think most of these companies do buybacks because it is the optimal deployment of capital though it is customary to dress it up as such. It is a transfer of wealth from the entire shareholder class to a very small percentage of shareholders- the executives who richly remunerate themselves with performance incentives in the form of shares since a very healthy base income is apparently insufficient motivation to provide optimal performance for the average executive.The effect of annual share bonuses to management is very small as a one off event but does become somewhat incrementally significant over time and necessitates buybacks so that the value of the free executive (and other shareholders') shares is maintained by using the company profits (that is profits which should accrue to all shareholders) to buy and cancel company shares and keep the number of outstanding shares relatively constant.
- Forums
- ASX - By Stock
- MQG
- Ann: Macquarie Group 1H24 Presentation
MQG
macquarie group limited
Add to My Watchlist
1.10%
!
$216.87

Ann: Macquarie Group 1H24 Presentation, page-43
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$216.87 |
Change
2.370(1.10%) |
Mkt cap ! $82.65B |
Open | High | Low | Value | Volume |
$215.34 | $217.61 | $213.70 | $124.0M | 572.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3 | $216.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$217.00 | 236 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2258 | 227.710 |
3 | 607 | 218.200 |
1 | 5 | 217.500 |
1 | 1 | 217.300 |
1 | 111 | 217.000 |
Price($) | Vol. | No. |
---|---|---|
206.250 | 10 | 1 |
207.100 | 573 | 2 |
212.000 | 10 | 1 |
214.960 | 86 | 1 |
216.000 | 55 | 2 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
MQG (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online